Literature DB >> 26207591

OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.

Weiwei Huang1, Shijie Wang1, Yufeng Yao1, Ye Xia1, Xu Yang1, Qiong Long1, Wenjia Sun1, Cunbao Liu1, Yang Li1, Yanbing Ma2.   

Abstract

Acinetobacter baumannii (A. baumannii) is an important conditioned pathogen that causes nosocomial and community-associated infections. In this study, we sought to investigate whether outer membrane protein W (OmpW) is a potential target for eliciting protective immunity against A. baumannii infections. Mice immunized with the fusion protein thioredoxin-OmpW generated strong OmpW-specific IgG responses. In a sepsis model, both active and passive immunizations against OmpW effectively protected mice from A. baumannii infections. This protection was demonstrated by a significantly improved survival rate, reduced bacterial burdens within organs, and the suppressed accumulation of inflammatory cytokines and chemokines in sera. Opsonophagocytic assays with murine macrophage RAW264.7 cells indicated that the bactericidal effects of the antisera derived from the immunized mice are mediated synergistically by specific antibodies and complement components. The antisera presented significant opsonophagocytic activities against homologous strains and clonally distinct clinical isolates in vitro. Protein data analysis showed that the sequence of OmpW, which has a molecule length of 183 amino acids, is more than 91% conserved in reported A. baumannii strains. In conclusion, we identified OmpW as a highly immunogenic and conserved protein as a valuable antigen candidate for the development of an effective vaccine or the preparation of antisera to control A. baumannii infections.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acinetobacter baumannii; Outer membrane protein W; Protective immunity; Vaccine

Mesh:

Substances:

Year:  2015        PMID: 26207591     DOI: 10.1016/j.vaccine.2015.07.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Cloning and expression of nlpA gene as DNA vaccine candidate against Acinetobacter baumannii.

Authors:  Rassoul Hashemzehi; Abbas Doosti; Mohammad Kargar; Mojtaba Jaafarinia
Journal:  Mol Biol Rep       Date:  2018-05-22       Impact factor: 2.316

Review 2.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 3.  Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.

Authors:  Brent S Weber; Christian M Harding; Mario F Feldman
Journal:  J Bacteriol       Date:  2015-12-28       Impact factor: 3.490

4.  Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.

Authors:  Weiwei Huang; Shijie Wang; Yufeng Yao; Ye Xia; Xu Yang; Kui Li; Pengyan Sun; Cunbao Liu; Wenjia Sun; Hongmei Bai; Xiaojie Chu; Yang Li; Yanbing Ma
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

5.  Identification of immunogenic outer membrane proteins and evaluation of their protective efficacy against Stenotrophomonas maltophilia.

Authors:  Guangyang Xu; Xueping Tang; Xueyi Shang; Yan Li; Jing Wang; Junjie Yue; Yan Li
Journal:  BMC Infect Dis       Date:  2018-07-27       Impact factor: 3.090

6.  Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection.

Authors:  Abolfazl Jahangiri; Parviz Owlia; Iraj Rasooli; Jafar Salimian; Ehsan Derakhshanifar; Zahra Aghajani; Sajad Abdollahi; Saeed Khalili; Daryush Talei; Elham Darzi Eslam
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

7.  Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.

Authors:  Ravinder Singh; Neena Capalash; Prince Sharma
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

8.  Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain, Acinetobacter baumannii DU202.

Authors:  Sung Ho Yun; Edmond Changkyun Park; Sang-Yeop Lee; Hayoung Lee; Chi-Won Choi; Yoon-Sun Yi; Hyun-Joo Ro; Je Chul Lee; Sangmi Jun; Hye-Yeon Kim; Gun-Hwa Kim; Seung Il Kim
Journal:  Clin Proteomics       Date:  2018-08-31       Impact factor: 3.988

9.  Acinetobacter spp. porin Omp33-36: Classification and transcriptional response to carbapenems and host cells.

Authors:  Katarina Novović; Sanja Mihajlović; Miroslav Dinić; Milka Malešević; Marija Miljković; Milan Kojić; Branko Jovčić
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

Review 10.  Acinetobacter baumannii: An Ancient Commensal with Weapons of a Pathogen.

Authors:  Meysam Sarshar; Payam Behzadi; Daniela Scribano; Anna Teresa Palamara; Cecilia Ambrosi
Journal:  Pathogens       Date:  2021-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.